LAUSR

Stochastic frontier analysis (SFA) is used as a novel knowledge-based technique in order to develop a predictive model of dosimetric features from significant geometric parameters describing a patient morphology. 406 patients treated with VMAT for prostate cancer were analyzed retrospectively. Cases were divided into three prescription-based groups. Seven geometric parameters are extracted to characterize the relationship between the organs-at-risk (bladder and rectum) with the planning volume (PTV). In total, 37 dosimetric parameters are tested for these two OARs. SFA allows the determination of the minimum achievable dose to the OAR based on the geometric parameters. Stochastic frontiers are determined with a maximum likelihood estimation technique. The SFA model was tested using validation cohort (30 patients with prescribed dose between 60 and 70 Gy) where 77% (23 out of 30) of the predicted DVHs present a 5% or less dose deterioration for the bladder and rectum with the planned DVH. SFA can be used in EBRT planning as a predictive model based on anatomical features of previously treated plans.